guaifenesin and dextromethorphan hbr
Generic: guaifenesin and dextromethorphan hbr
Labeler: target corporationDrug Facts
Product Profile
Brand Name
guaifenesin and dextromethorphan hbr
Generic Name
guaifenesin and dextromethorphan hbr
Labeler
target corporation
Dosage Form
TABLET, EXTENDED RELEASE
Routes
Active Ingredients
dextromethorphan hydrobromide 60 mg/1, guaifenesin 1200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
11673-267
Product ID
11673-267_b50d26f2-6f4d-4430-9f6c-4d10bc893e75
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA206941
Listing Expiration
2026-12-31
Marketing Start
2024-07-04
Pharmacologic Class
Established (EPC)
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
11673267
Hyphenated Format
11673-267
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
guaifenesin and dextromethorphan hbr (source: ndc)
Generic Name
guaifenesin and dextromethorphan hbr (source: ndc)
Application Number
ANDA206941 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 60 mg/1
- 1200 mg/1
Packaging
- 1 BOTTLE in 1 CARTON (11673-267-05) / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE
- 1 BOTTLE in 1 CARTON (11673-267-57) / 28 TABLET, EXTENDED RELEASE in 1 BOTTLE
- 1 BOTTLE in 1 CARTON (11673-267-60) / 42 TABLET, EXTENDED RELEASE in 1 BOTTLE
Packages (3)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b50d26f2-6f4d-4430-9f6c-4d10bc893e75", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["9D2RTI9KYH", "495W7451VQ"], "rxcui": ["1099074"], "spl_set_id": ["15434143-ab8e-4cf9-e063-6394a90a2388"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["Target Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (11673-267-05) / 14 TABLET, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "11673-267-05", "marketing_start_date": "20240704"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (11673-267-57) / 28 TABLET, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "11673-267-57", "marketing_start_date": "20240704"}, {"sample": false, "description": "1 BOTTLE in 1 CARTON (11673-267-60) / 42 TABLET, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "11673-267-60", "marketing_start_date": "20240704"}], "brand_name": "Guaifenesin and Dextromethorphan HBr", "product_id": "11673-267_b50d26f2-6f4d-4430-9f6c-4d10bc893e75", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]"], "product_ndc": "11673-267", "generic_name": "Guaifenesin and Dextromethorphan HBr", "labeler_name": "Target Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Guaifenesin and Dextromethorphan HBr", "active_ingredients": [{"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "60 mg/1"}, {"name": "GUAIFENESIN", "strength": "1200 mg/1"}], "application_number": "ANDA206941", "marketing_category": "ANDA", "marketing_start_date": "20240704", "listing_expiration_date": "20261231"}